Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDFortress Biotech Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.22 | -$0.22 | -$0.22 |
| Q2 2026 | 1 | -$0.19 | -$0.19 | -$0.19 |
| Q3 2026 | 1 | -$0.16 | -$0.16 | -$0.16 |
| Q4 2026 | 1 | -$0.14 | -$0.14 | -$0.14 |
Fortress Biotech Inc Earnings Date And Information
Fortress Biotech Inc last posted its earnings results on Tuesday, March 31st, 2026. The company reported $-0.21 earnings per share for the quarter, missing analysts' consensus estimates of $0.42 by $0.63. The company had revenue of 16.07 M for the quarter and had revenue of 63.26 M for the year. Fortress Biotech Inc has generated $0 earnings per share over the last year ($-0.0674 diluted earnings per share) and currently has a price-to-earnings ratio of 9.25. Fortress Biotech Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Fortress Biotech Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/31/2026 | Q4 2025 | $0.42 | -$0.22 | -0.64 | $26.17 M | $16.07 M |
| 11/14/2025 | Q3 2025 | -$0.43 | $0.13 | 0.56 | $21.02 M | $17.63 M |
| 08/14/2025 | Q2 2025 | -$0.31 | $0.50 | 0.81 | $14.53 M | $16.41 M |
| 05/15/2025 | Q1 2025 | N/A | -$0.48 | N/A | $11.62 M | $13.14 M |
| 03/31/2025 | Q4 2024 | N/A | -$0.37 | N/A | $14.58 M | $15.12 M |
| 11/14/2024 | Q3 2024 | -$0.27 | -$0.76 | -0.49 | $32.22 M | $14.63 M |
| 08/13/2024 | Q2 2024 | -$1.32 | -$0.73 | 0.59 | $14.75 M | $14.90 M |
| 05/15/2024 | Q1 2024 | -$2.03 | -$1.03 | 1 | N/A | $13.03 M |
| 03/28/2024 | Q4 2023 | -$1.97 | -$1.19 | 0.78 | N/A | $19.95 M |
| 09/29/2023 | Q3 2023 | N/A | -$0.94 | N/A | N/A | $34.75 M |
| 08/14/2023 | Q2 2023 | -$3.90 | -$3.65 | 0.25 | N/A | $17.39 M |
| 05/15/2023 | Q1 2023 | -$2.85 | -$3.47 | -0.62 | N/A | $12.43 M |
| 03/31/2023 | Q4 2022 | N/A | -$7.80 | N/A | N/A | $16.40 M |
| 11/14/2022 | Q3 2022 | -$4.05 | -$4.11 | -0.06 | N/A | $16.53 M |
| 08/11/2022 | Q2 2022 | -$3.00 | -$3.90 | -0.9 | N/A | $18.89 M |
| 05/12/2022 | Q1 2022 | -$4.20 | -$2.70 | 1.5 | N/A | $23.93 M |
| 03/28/2022 | Q4 2021 | $1.50 | -$5.66 | -7.16 | N/A | $18.28 M |
| 11/15/2021 | Q3 2021 | -$1.20 | -$3.83 | -2.63 | N/A | $21.09 M |
| 08/16/2021 | Q2 2021 | -$2.10 | -$0.65 | 1.45 | N/A | $17.84 M |
| 05/17/2021 | Q1 2021 | N/A | -$1.64 | N/A | N/A | $11.59 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Fortress Biotech Inc Earnings: FAQ's
The conference call for Fortress Biotech Inc's latest earnings report can be listened to online.
The conference call transcript for Fortress Biotech Inc's latest earnings report can be read online.
Fortress Biotech Inc (:FBIO) has a recorded annual revenue of $63.26 M.
Fortress Biotech Inc (:FBIO) has a recorded net income of $6.82 M.Fortress Biotech Inc has generated $-0.0674 earnings per share over the last four quarters.
Fortress Biotech Inc (:FBIO) has a price-to-earnings ratio of 9.25 and price/earnings-to-growth ratio is 0.02.